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Abstract 
The aim is to highlight the progress of earliness and quality of diagnosis and breast cancer cure in the Province 
of Lecce by surveying a number of indicators obtainable from surgical pathologist’s evaluation. The study, con-
ducted with the software SQTM (www.qtweb.it), is based on breast cancer of women  50-69 years old residing in 
the Province of Lecce  who undergone breast surgery in the years 2003, 2004, 2010, 2011 and 2012 at the "V. 
Fazzi " Hospital, which is reference center for diagnosis and treatment of breast cancer  within the Breast Cancer 
Screening Program of the ASL of Lecce , active since 2008. Compared to the prescreening period, results of all 
the indicators showed an almost progressive and significant improvement along the years, highlighting the first 
beneficial effects, primarily the improvement of early diagnosis, resulting from the impact of screening on the 
female  target population. However, the study has emphasized some important problems arising from persistent 
and systematic deficiencies in the organizational and multidisciplinary approach, on which we must concentrate 
efforts to further improve the screening program results. 
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Introduction 
 
The Planned Mammographic Screening (PMS) 
for breast cancer, with the uterine cervix cancer  
screening and  the colon-rectum one’s, is part 
of LEA (Essential Assistance Levels) in Italy 
from several years, implying  the national and 
regional sanitary service assure all the women 
from the target population (50-69 year old) of 
active measures for early diagnosis, based on 
mammography as the first level test carried out 
after a call once every two years. The planned 
screening’s first aim is to reduce mortality for 
all the neoplasias  is addressed to,  with an ac-
ceptable cost/benefit ratio. The second aim is 
to improve the diagnostic and therapeutic  
course quality.  So a planned screening program 
is not limited to appropriate organizational 
measures for a good coverage and compliance 
of the target population in first level testing , it 
provides also a good management of  a right 
diagnostic and therapeutic course, a control sys-
tem and checking the results and a continuous 
action to straighten the shot of screening or-
ganizational machine.  From 2006 is available 
the SQTM (computerized Schedule for Quality  
in Treatment of Mammary carcinoma) dedicat-
ed software developed by Piedmont’s  CPO 
(regional Oncological Prevention Center) with 
European funds from the “Europe against can-
cer” Program and under the auspices of 
EUSOMA.  SQTM is used from several years 
by GISMa (Mammographic Screening Italian 
Group) to do year’s surveys on mammographic 
screening results in Italy, based on monitoring 
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many quality’s indicators of diagnosis and 
treatment. 
 
 
Objective 
  
The aim of this study is to evaluate, by some 
GISMa’s indicators, the quality trend of diagno-
sis and treatment of the mammary carcinoma in 
Salento over a period of ten years during which 
the PMS was introduced in Lecce’s district 
(800.000 residents).  The study is based on cas-
es of breast pathology observed in resident 
women operated at “Vito Fazzi” General Hos-
pital of Lecce, the biggest one in the district, 
that is home to breast unit and also reference 
center for diagnosis and for treatment of 
screen-detected cases of breast carcinoma in the 
PMS of  the ASL of Lecce  (local health author-
ity). PMS in Lecce’s district is  active from 
2008. The cases falling in the study were ob-
served during the years 2003, 2004, 2010, 2011 
and 2012 and were registered with SQTM. 
Their files have been analyzed in partnership 
with Piedmont’s CPO. This work is part of a 
collaboration in monitoring program for 
mammographic screening in Italy, in which 
Lecce’s team is so far the only one from South-
ern Italy. Preliminary data for the years 2003, 
2004 and 2010 only were presented at the 
GISMa’s National Meeting of Palermo in 2011 
(Delos, Tarantino, Olla Atzeni et al. 2011) .   
The years 2003 and 2004 were evaluated for 
prescreening results. On the other side the years 
from 2010 were examined for any positive im-
pact of the local PMS on the target population. 
With this work we hope provide useful 
informations to solve any critical issues of local 
PMS. From Cancer Registry of Lecce’s district 
we can notice an incidence of about 500 breast 
malignant neoplasias a year in women 
(Melcarne, Rashid, Quarta 2010) .  
 
 
In the Graphic 1 we can observe breast malig-
nant tumors, distributed by age groups, in the 
2007, most recent year published available.  
 
 
 
In the Graphic 2, reporting  the same cases dis-
tributed by hospitals of surgical treatment, we 
can observe that 37% of malignant breast tu-
mors was operated at “Vito Fazzi” General 
Hospital of Lecce. 
 
 
Materials and methods  
 
This study concerns malignant and benign  
desease  cases of the breast regarding women 
operated in the years 2003, 2004, 2010, 2011 
and 2012 at Vito Fazzi General Hospital, where 
are treated surgically about 200 breast carcino-
ma cases for year, that is 37% of all breast ma-
lignant tumors cases incident in women of Lec-
ce’s district. All the cases were registered in 
SQTM by Surgical Pathology Unit of “Vito 
Fazzi” Hospital.  For this first evaluation we 
haven’t taken in to account all the indicators of 
the GISMa’s surveys, but only those that usual-
ly can be deduced by the Surgical Pathology’s 
diagnostic report. In particular for this study we 
have calculated with SQTM the values of the 
following indicators: 
1) Pre-operative diagnosis in cancer 
(C5/B5) 
2) Completeness of diagnostic and prog-
nostic data in surgical pathology’s re-
port of invasive cancer  cases (histotype, 
grading,  pTNM)  
3) Only one operation after pre-operative 
diagnosis of invasive cancer 
4) Only one operation after pre-operative 
diagnosis of non-invasive cancer (in situ 
carcinoma) 
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5) Axillary staging by Sentinel Lymph 
Node (SLN) only in pN0   
6) No axillary dissection in Ductal Carci-
noma in Situ (DCIS) 
7) Conservative surgery (quadrantectomy) 
in invasive  cancers </=  30 mm  
8) Immediate plastic reconstruction in in-
vasive carcinoma cases  treated  with to-
tal mastectomy 
9) pN0 in invasive cancer cases 
10) Early diagnosis (pTis + pTmc + pT1a 
+ pT1b) in all cancer cases   
11) Benign/Malignant ratio (B/M) in surgi-
cally treated cases 
 
Indicators from 1 to 8 are GISMa’s ones 
(Mano, Ponti, Angiolini et al 2013) . Indicators 
from 9 to 11 usually are not reported in 
GISMa’s Surveys, but they are anyway calculat-
ed for this study and comparated with the cor-
responding values achieved from data of 
GISMa’Survey 2012 (Ponti, Mano, Tomatis et 
al. 2015). 
 
 
Results 
 
We can find in Table 1 the obtained values, re-
ported as cases number and percentages dis-
tributed by years of treatment, for all the differ-
ent indicators considered. The years 2003 and 
2004 are reported together. In the same table  
are reported the corresponding values of the 
national GISMa’s Survey 2012.   
 
 
 
In Graphic 3 we reported changes over time in 
the pT distribution in breast cancer detected 
among women aged between 45 and 70 years, 
who are the ones that benefit most from the 
PMS.  
Indicator n. 1 increases from 17,2% of the pre-
screening period to the 29% for 2011 and to 
23% for 2012. Indicator n. 2 increases from 
31% to 74,7% in 2012. Indicator n. 3 remained 
nearly the same only with little variations over 
time. Indicator n. 4 gets better, from 61,5% of 
2003-2004 to 87,5% of 2012. Indicator n. 5 in-
creases from 29,5% to 63,6%.  Indicator n. 6  
doesn’t improve so much, but it has little varia-
tions (from 76,9% to 80%). Indicator n. 7 has 
improved only slightly over time (from 63,8% 
to 66,7%). Indicator n. 8 increased by 10% over 
time, but started from 0 in the prescreening pe-
riod. Both indicators n. 9 and n. 10 improved a 
little, from 54,9% to 58,2% the first,  from 
31,3% to 37,2% the second.  But in Graphic 3 
you can see that pT distribution highlighted 
changes indicative of an earlier diagnosis in the 
years of PMS. In particular they are increased 
cases of carcinoma in situ, microinvasive carci-
nomas and carcinoma within 1 cm and de-
creased cases of carcinoma above 2 cm. Indica-
tor n. 11, expressed as a ratio, has gotten a lot 
better, gradually improving from 1,41 of the 
prescreening period to 0,56 of 2012.  
 
 
Discussion  
 
The results of this investigation highlight an 
almost progressive and significant improvement 
of all the indicators over time from the pre-
screening period, that is years 2003 and 2004,  
when in the Lecce’s district the early diagnosis 
for mammary tumors wasn’t planned or orga-
nized but it only depended on women them-
selves. In details we want to underline, first of 
all, that the improvement of indicators 9 and 10 
is expression of a meaningful, although initial, 
effect of PMS in diagnostic earliness. Over 
time, in effect, in years of PMS we diagnosed 
more mammary neoplasias of little dimensions 
and that doesn’t affect axillary lymph nodes 
than in the prescreening period. Anyway the 
recorded improvement of these two indicators 
is not satisfactory yet, being their values distant 
from GISMa’s values of 2012 (72,6 and 49,7 re-
spectively), although during 2011 they  got 
nearer (70,2 and 38,8). But we have to pay at-
tention to the fact that GISMa’s values are rep-
resentative of geographic areas of Northern Ita-
ly where PMS, in activity from 90’s, are the re-
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sult of decades of experience and organization 
that allows higher levels of coverage and com-
pliance, as well as a quality of diagnostic and 
therapeutic courses  certainly superiors than in 
Lecce’s experience that was just starting in the 
years of this study. We think however that this 
first result of PMS in Salento, talking about 
more precocious diagnosis, as  highlighted by 
moderate improvement of indicators 9 and 10, 
is important and indicative about what potential 
can be developed over time with an implemen-
tation of screening activities. Particularly posi-
tive was the result of indicator n. 2, typical pro-
cess indicator, that recorded progressive grow-
ing values until it goes over the medium 
GISMa’s survey value (74,7% versus 62,6%). 
This result attests the elevated level reached in 
the ASL of Lecce by the breast surgical pathol-
ogy, that is essential base for appropriateness 
and quality of medical care. About the appro-
priateness for the surgery treatment, we have 
used the indicators from number 3 to 7. Their 
monitoring is useful to pursue a double objec-
tive, on the one hand, of avoiding useless and 
more invasive surgery in favor of the patients 
and, on the other, of saving costs and operating 
room resources. The results regarding the sur-
gical appropriateness were contradictory.  If for 
the indicators 3, 4 and 6 we had remarkable 
values, that improved significantly on time, 
aligning in 2011 to GISMa’s values, indicators 
n. 5 and 7 were disappointing (63,6 and 66,7 re-
spectively), remaining far below of the GISMa’s 
values (91,7 and 83,5). Essentially it seems like 
the conservative surgery is still inadequately ap-
plied, in particular, regarding quadrantectomy 
instead of total mastectomy, as  in effect is 
highlighted by indicator 7, which improved a 
little during years of PMS. Regarding the saving 
of axillary dissection in pN0 cases (indicator n. 
5), the sentinel lymph node technique was still 
underused, although this parameter significantly 
improved if compared with the value (29,5%) 
of prescreening period.  But the most critical 
aspects are those remarked by indicators n. 1, 8 
and 11. Very negative is the result of indicator 
n. 1, for the systemic implications on all the di-
agnostic and therapeutic course and, in particu-
lar, for its adverse effect on appropriateness of 
surgical treatment. The value of this indicator  
improved very little, from 17,2% to 23%,  re-
maining far below of the GISMa’s value 
(82,3%).  Despite this negative result we had 
positive values of  indicators  3, 4, 6, as men-
tioned above,  but this implies  a systematic 
trend to  bypass  the pre-operative diagnosis  by 
fine needle aspiration and/or needle biopsy, in 
favor of intra-operative diagnosis based on fro-
zen sections.  This practice is inadequate for 
several reasons and seems to be the heritage of 
the past when the surgeon was the only and al-
most exclusive reference for the breast  pathol-
ogy  treatment. This practice should be aban-
doned  in favor of the current good clinical 
practice recommendations because it causes the 
following negative consequences:  
1) Increased costs due to overuse of intra-
operative diagnosis, more expensive 
than the pre-operative one, as it length-
ens the operating room time,  requires 
the commitment of the medical and 
technical staff of surgical pathology dur-
ing operations, brings to the operating 
table, as the indicator 11 remarks, many 
benign lesions, with a further consump-
tion of resources and exposition to risk 
and discomfort the women unnecessari-
ly operated; 
2) lowering of the quality and appropriate-
ness  of the treatment plan due to by-
passing the multidisciplinary assessment 
in pre-operative phase, leaving every 
decision to surgeon;  
3) Exclusion of woman/patient from a 
decision regarding the treatment be-
cause she is under anesthesia when a 
decision is taken after a intra-operative 
diagnosis: the  consequent implications, 
also talking about legal validity of con-
sent to the treatment, can be easily un-
derstand. 
About the very low value of indicator n. 8, re-
garding the plastic reconstruction of breast after 
total mastectomy, in part it’s due to the multi-
disciplinary planning deficits of the diagnostic-
therapeutic courses and to underuse of the pre-
operative diagnosis.     
 
 
Conclusions 
  
From the results described above, albeit relative 
to a still initial period of introduction of the 
PMS in the district of the ASL of Lecce, with 
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the consequent and deducible limits both in 
terms of effective coverage of the target popu-
lation and compliance of the invited women 
who appeared    to be low (around the 40%),  
emerges already the capacity of this important 
early diagnosis planning tool.  But also they 
emerge several critical issues that are 
attributable mainly to a deficit with regard to 
the approach and organization of 
multidisciplinary preoperative diagnostic and 
therapeutic planning process. These problems 
must be resolved through the efforts of medical 
teams involved , the Breast Unit, the body of 
the local PMS coordination and the 
management of the local health institutions. As 
the persistence over time of these critical issues 
, and still others in this study were not 
examined , produces the effect of devaluing the 
screening program, it is important to implement 
a systematic monitoring of the results with 
appropriate tools, to  constantly correct the 
shooting of PMS and improve the quality of 
diagnostic and therapeutic path of breast cancer 
in the ASL of Lecce district. 
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